GlassScriptPhysician profile
Peter White Whitfield
NPI 1700838828
$385.91
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $28.03 · 2021: $114.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $76.94 | 2021 | |
| Abbvie INC. | $61.04 | 2019 | |
| Radius Health, INC. | $50.49 | 2019-2020 | |
| Amgen INC. | $50.11 | 2019 | |
| Ucb, INC. | $41.33 | 2019 | |
| Vericel Corporation | $25.64 | 2021 | |
| Celgene Corporation | $22.81 | 2019 | |
| Mallinckrodt Enterprises LLC | $20.88 | 2019 | |
| Pfizer INC. | $13.69 | 2019 | |
| Lilly USA, LLC | $11.94 | 2020 | |
| Smith+Nephew, INC. | $11.04 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Whitfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.